MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/strokeaha.117.019810

Медицинская библиотека · Stroke · 2018

Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.

van Leijsen Esther M C, Kuiperij H Bea, Kersten Iris, Bergkamp Mayra I, van Uden Ingeborg W M, Vanderstichele Hugo, Stoops Erik, Claassen Jurgen A H R, van Dijk Ewoud J, de Leeuw Frank-Erik, Verbeek Marcel M

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND PURPOSE: Cerebral small vessel disease (SVD) is a frequent pathology in aging and contributor to the development of dementia. Plasma Aβ (amyloid β) levels may be useful as early biomarker, but the role of plasma Aβ in SVD remains to be elucidated. We investigated the association of plasma Aβ levels with severity and progression of SVD markers.

METHODS

We studied 487 participants from the RUN DMC study (Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Imaging Cohort) of whom 258 participants underwent 3 MRI assessments during 9 years. We determined baseline plasma Aβ38, Aβ40, and Aβ42 levels using ELISAs. We longitudinally assessed volume of white matter hyperintensities semiautomatically and manually rated lacunes and microbleeds. We analyzed associations between plasma Aβ and SVD markers by ANCOVA adjusted for age, sex, and hypertension.

RESULTS

Cross-sectionally, plasma Aβ40 levels were elevated in participants with microbleeds (mean, 205.4 versus 186.4 pg/mL; P<0.01) and lacunes (mean, 194.8 versus 181.2 pg/mL; P<0.05). Both Aβ38 and Aβ40 were elevated in participants with severe white matter hyperintensities (Aβ38, 25.3 versus 22.7 pg/mL; P<0.01; Aβ40, 201.8 versus 183.3 pg/mL; P<0.05). Longitudinally, plasma Aβ40 levels were elevated in participants with white matter hyperintensity progression (mean, 194.6 versus 182.9 pg/mL; P<0.05). Both Aβ38 and Aβ40 were elevated in participants with incident lacunes (Aβ38, 24.5 versus 22.5 pg/mL; P<0.05; Aβ40, 194.9 versus 181.2 pg/mL; P<0.01) and Aβ42 in participants with incident microbleeds (62.8 versus 60.4 pg/mL; P<0.05).

CONCLUSIONS

Plasma Aβ levels are associated with both presence and progression of SVD markers, suggesting that Aβ pathology might contribute to the development and progression of SVD. Plasma Aβ levels might thereby serve as inexpensive and noninvasive measure for identifying individuals with increased risk for progression of SVD.

Для цитирования: van Leijsen Esther M C, Kuiperij H Bea, Kersten Iris, Bergkamp Mayra I, van Uden Ingeborg W M, Vanderstichele Hugo, Stoops Erik, Claassen Jurgen A H R, van Dijk Ewoud J, de Leeuw Frank-Erik, Verbeek Marcel M. Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.. Stroke. 2018. DOI: 10.1161/strokeaha.117.019810.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.